Abingdon Health announces its latest expansion and
additional manufacturing capacity
Investment
in state-of-the-art automation cements Abingdon Health’s position as a leading
global rapid test manufacturer
Abingdon Health is pleased to announce further
expansion at its York headquarters in the UK, following further investment in
state-of-the-art lateral flow automation. This will provide a significant
increase in its manufacturing footprint, resulting in Europe’s largest capacity
for rapid test manufacturing. This news comes weeks after the UK Government
announced Abingdon Health as one of the leading members of the UK Rapid Test
Consortium (UK-RTC).
Earlier this year, Abingdon Health announced a
preliminary round of expansion in York after 90 % revenue growth in 2019,
thanks to new assay developments and assay manufacturing contract wins, and the
introduction of its AppDx Smartphone reader software. In April 2020, growth
continued with the acquisition of a new lateral flow manufacturing facility in
Doncaster, UK. This latest expansion and investment in equipment, which has
been captured in a new video, comes as 2020 sees
continuing high demand for Abingdon Health’s services.
Abingdon Health’s two manufacturing sites in
York and Doncaster have the capacity to produce millions of rapid tests per
month for clients across many industries. This adaptable, dual-site approach
forms a peace-of-mind solution that assures customers receive product
consistency and a security of supply during routine scheduling and spikes in
demand.
Michael Hunter, Operations Director of Abingdon
Health, commented:
“The additional footprint and automation come
at a timely moment as demand for rapid tests is growing rapidly, with the
market likely to exceed $10bn globally. Our precision automation and multi-site
approach means we can adapt to meet the varying manufacturing needs of our
growing global client base.”
About
Abingdon Health
Abingdon Health is a technology-enabled lateral
flow diagnostics company providing innovative rapid testing solutions to a
multi-industry, global client base. Abingdon Health provides specialist assay
development and smartphone reader solutions alongside Europe’s largest lateral
flow test manufacturing capacity. By combining a multi-disciplinary approach
with precision automation, Abingdon Health assures product consistency and
security of supply for the most complex of assays and markets. Abingdon Health
takes projects from initial concept through scale-up and into high-volume
manufacturing, in addition to accommodating clients looking to transfer their
rapid test from third-party developers or manufacturers.
Abingdon Health is headquartered in York,
United Kingdom. Visit www.abingdonhealth.com.